Minerva Neurosciences, Inc. (NERV) NASDAQ

2.34

-0.0141(-0.60%)

Updated at September 08 01:03PM

Currency In USD

Valuation

Market Cap16.8M
Enterprise Value55.44M
P/E Ratio1.55
PEG Ratio0.02
Price/Sales Ratio381.82
Price/Book Ratio-0.54
Enterprise/Revenue1,441.85
Enterprise/EBITDA5.42

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin265.99
Operating Margin-382.92

Management Effectiveness

Return On Assets0.37
Return On Equity-0

Income Statement

Revenue0
Revenue/Share0.01
Gross Profit-22,469
EBITDA6.02M
Net Income1.44M
Diluted EPS0.19

Balance Sheet

Total Cash15.25M
Total Cash/Share2.01
Total Debt60M
Total Debt/Equity-1.87
Current Ratio6.15
Book Value Per Share-4.24

Price History

52-Week Change-16.49
52-Week High3
52-Week Low1.15
Moving Average 50 Days2
Moving Average 200 Days1.91

Statistics

Average Volume22,254
Shares Outstanding6.99M
% Held by Institutions25.54

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:8
Last Split DateJune 21, 2022